About Serine protease HTRA3
Serine protease HTRA3 (HTRA3) is a protein
from Homo sapiens identified by UniProt accession
P83110, 453 residues long.
MolForge cross-references it against 0 known binders and
39 disease associations.
Target properties
| Protein name | Serine protease HTRA3 |
| UniProt accession | P83110 |
| Gene | HTRA3 |
| Organism | Homo sapiens |
| Length | 453 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (39)
Diseases linked to this target (Open Targets).
- pulse pressure measurement · score 0.34
- carpal tunnel syndrome · score 0.33
- systolic blood pressure · score 0.16
- genetic disorder · score 0.12
- aspartate aminotransferase measurement · score 0.10
- low density lipoprotein cholesterol measurement · score 0.08
- total cholesterol measurement · score 0.08
- gonorrhea · score 0.05
- esophageal squamous cell carcinoma · score 0.05
- drug use measurement · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P83110-F1 | alphafold | PREDICTED | 84.50 | — |
Amino-acid sequence (453 residues)
MQARALLLAA LAALALAREP PAAPCPARCD VSRCPSPRCP GGYVPDLCNC CLVCAASEGE PCGGPLDSPC GESLECVRGL CRCRWSHAVC GTDGHTYANV CALQAASRRA LQLSGTPVRQ LQKGACPLGL HQLSSPRYKF NFIADVVEKI APAVVHIELF LRHPLFGRNV PLSSGSGFIM SEAGLIITNA HVVSSNSAAP GRQQLKVQLQ NGDSYEATIK DIDKKSDIAT IKIHPKKKLP VLLLGHSADL RPGEFVVAIG SPFALQNTVT TGIVSTAQRE GRELGLRDSD MDYIQTDAII NYGNSGGPLV NLDGEVIGIN TLKVTAGISF AIPSDRITRF LTEFQDKQIK DWKKRFIGIR MRTITPSLVD ELKASNPDFP EVSSGIYVQE VAPNSPSQRG GIQDGDIIVK VNGRPLVDSS ELQEAVLTES PLLLEVRRGN DDLLFSIAPE VVM
Explore Serine protease HTRA3 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets